Australia's HPV Vaccine Program Achieves 61% Reduction of Genital Warts

被引：0
|
作者：
不详
机构：
来源：
HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2014年 / 10卷 / 09期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：2516 / 2516
页数：1
相关论文
共 50 条
  • [41] Association between sexual mixing and genital warts in heterosexual men in Australia: the herd protection from the female human papillomavirus vaccination program
    Chow, Eric P. F.
    Fairley, Christopher K.
    SEXUAL HEALTH, 2016, 13 (05) : 489 - 490
  • [42] Significant Reduction in the Incidence of Genital Warts in Young Men 5 Years Into the Danish Human Papillomavirus Vaccination Program for Girls and Women
    Bollerup, Signe
    Baldur-Felskov, Birgitte
    Blomberg, Maria
    Baandrup, Louise
    Dehlendorff, Christian
    Kjaer, Susanne K.
    SEXUALLY TRANSMITTED DISEASES, 2016, 43 (04) : 238 - 242
  • [43] Phase I safety and antigenicity of TA-GW: a recombinant HPV6 L2E7 vaccine for the treatment of genital warts
    Thompson, HSG
    Davies, ML
    Holding, FP
    Fallon, RE
    Mann, AE
    O'Neill, T
    Roberts, JSC
    VACCINE, 1999, 17 (01) : 40 - 49
  • [44] Preliminary trends of reduction in genital warts in Campos dos Goytacazes, Rio de Janeiro, Brazil, 3 years after started quadrivalent HPV vaccination
    Kury, C. M. H.
    Vitral, C. L.
    Kury, M. M. H.
    Silva, R. M. H.
    Cirilli, B.
    Oliveira, F. A. S.
    Morais, J. G. S. A.
    Pereira, C. C. R.
    8TH WORLD CONGRESS OF THE WORLD SOCIETY FOR PEDIATRIC INFECTIOUS DISEASES (WSPID), 2014, : 49 - 51
  • [45] HPV VACCINE AND ERADICATION OF CERVICAL CANCER Following Australia's lead to eradicate cervical cancer
    Bralsford, Keira J.
    BMJ-BRITISH MEDICAL JOURNAL, 2019, 366
  • [46] Estimation of the epidemiological burden of HPV-related anogenital cancers, precancerous lesions, and genital warts in women and men in Europe: Potential additional benefit of a nine-valent second generation HPV vaccine compared to first generation HPV vaccines
    Hartwig, Susanne
    Baldauf, Jean-Jacques
    Dominiak-Felden, Geraldine
    Simondon, Francois
    Alemany, Laia
    de Sanjose, Silvia
    Castellsague, Xavier
    PAPILLOMAVIRUS RESEARCH, 2015, 1 : 90 - 100
  • [47] Early impact of Ontario's human papillomavirus (HPV) vaccination program on anogenital warts (AGWs): A population-based assessment
    Guerra, Fiona M.
    Rosella, Laura C.
    Dunn, Sheila
    Wilson, Sarah E.
    Chen, Cynthia
    Deeks, Shelley L.
    VACCINE, 2016, 34 (39) : 4678 - 4683
  • [48] AN ASSESSMENT OF HUMAN PAPILLOMAVIRUS (HPV) VACCINE SERIES COMPLETION AND ON-TIME DOSING IN ONTARIO'S GRADE 8 HPV VACCINATION PROGRAM
    Smith, Leah
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2013, 67 (10)
  • [49] Age-specific HPV prevalence among 116,052 women in Australia's renewed cervical screening program: A new tool for monitoring vaccine impact
    Brotherton, Julia M. L.
    Hawkes, David
    Sultana, Farhana
    Malloy, Michael J.
    Machalek, Dorothy A.
    Smith, Megan A.
    Garland, Suzanne M.
    Saville, Marion
    VACCINE, 2019, 37 (03) : 412 - 416
  • [50] Reduction in Rotavirus-associated Acute Gastroenteritis Following Introduction of Rotavirus Vaccine Into Australia's National Childhood Vaccine Schedule
    Buttery, Jim P.
    Lambert, Stephen B.
    Grimwood, Keith
    Nissen, Michael D.
    Field, Emma J.
    Macartney, Kristine K.
    Akikusa, Jonathan D.
    Kelly, Julian J.
    Kirkwood, Carl D.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2011, 30 (01) : S25 - S29
12345